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Perchlorate is an inorganic compound that has
been manufactured and used as a solid rocket
fuel for several decades. Initial detection of per-
chlorate in drinking waters was associated with
proximity to military and industrial sites where
the compound was produced, stored, and/or
used. More recent data collection efforts sug-
gest perchlorate is more widespread than ini-
tially thought and in some locations may be
associated with sources other than military
rocket fuels. In some locations, perchlorate
may be present from commonly used explosive
devices (e.g., ﬁreworks, road blasting materials)
and in other locations the compound may be
formed naturally under suitable atmospheric
and soil conditions. For example, some
researchers hypothesize that lightning interac-
tions with desert soils containing certain salt
compounds may be responsible for perchlorate
levels detected in western Texas (Dasgupta
et al. 2005). Similar natural forces may explain
the presence of perchlorate in the Atacama
Desert region of Chile, and fertilizers mined
from the Chilean desert may contribute to per-
chlorate found in some areas of the United
States where those products were applied.
Perchlorate is among a class of goitergens
that inhibit the uptake of iodide by the thyroid
and thereby cause goiter and related iodine deﬁ-
ciency disorders (IDDs), including, in extreme
cases, cretinism. IDD is no longer considered a
public health concern in the United States
because the large majority of Americans have
ample iodide uptake through their normal diet
to prevent IDD. There is, however, a fraction of
pregnant women, between 10 and 15%, whose
urinary excretion rates are elevated (Hollowell
et al. 1998). If this increased urinary excretion
rate is interpreted as indicating a deficit of
iodine uptake (this link is not established in the
cited report), these women are likely to be the
sensitive subpopulation for perchlorate expo-
sures. Iodide intake is sufficient to typically
enable the thyroid to compensate and overcome
any adverse effects from goitergen exposure. It is
important to note that the effects of perchlorate
are therefore dependent on the total pool of
goitergens to which individuals are exposed.
Goitergen exposure in humans is from a
variety of routes, including both water inges-
tion and consumption of food products found
in the diet containing those with relatively high
levels of nitrate (fruits, vegetables, grains, drink-
ing water, and smoked meats), thiocyanates
(broccoli, cabbage, corn, yams, sorghum, and
milk), isoﬂavones (soy, beans, and peas), bro-
mide (drinking water), and disulﬁdes (onions,
garlic, and peas). Goitergen intake from per-
chlorate exposure in water must be compared
against this background of exposure to other
goitergens, with risks from perchlorate resulting
from the incremental effect of iodine uptake
inhibition above and beyond the inhibition
caused by the intake of other goitergens.
Presently, the relative effectiveness of these dif-
ferent routes of exposure at producing decreases
in iodine uptake has not been assessed, so it is
not possible to specify the fraction of total
decrease due solely to perchlorate exposures.
Overall goitergen exposure would need to
be quite high for iodide uptake to be inhibited
to a degree sufficient to elevate IDDs to a
matter of health concern, although again, this
level of exposure is not known at present and
may be significantly lower for the sensitive
subpopulation. The National Research
Council (NRC) examined the risks posed by
perchlorate ingestion (NRC 2005) and indi-
cated in their executive summary, “To cause
declines in thyroid hormone production that
would have adverse health effects, iodide
uptake would most likely have to be reduced
by at least 75% for months or longer.” The
mode of action for perchlorate exposure and
human health risk is summarized here in the
Appendix, based on the mode of action
described in the NRC (2005) report.
The NRC expert panel developed an oral
reference dose (RfD) of 0.0007 mg perchlo-
rate per kilogram of body weight per day
(mg/kg/day). This oral RfD is intended to
reﬂect a safe threshold dose at which no risk of
adverse health effect is anticipated for an
iodide-deficient pregnant woman and any
developing fetus she might be carrying. As
stated by the NRC (2005): “The committee
concludes that an RfD of 0.0007 mg/kg per
day should protect the health of even the most
sensitive populations.” This RfD is based on
observing no signiﬁcant inhibition of thyroid
uptake of iodide at a perchlorate dose of
0.007 mg/kg/day in human subjects (Greer
et al. 2002). A total uncertainty factor of 10
then was applied to ensure protection of the
sensitive subpopulation: iodide-deﬁcient preg-
nant women (and their fetuses). Such a sub-
population could be exposed to perchlorate
levels up to the RfD of 0.0007 mg/kg/day and
not be expected to face a significant risk of
adverse health effect. Because this is the most
sensitive population, this RfD also would be
protective of all other exposed individuals
(including infants).
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This article is a brief review and summary of the estimated incremental risks (increases in hazard
quotient or decreases in thyroid uptake of iodine) to pregnant women (and hence their fetuses)
associated with perchlorate exposure in community water supplies (CWSs). The analysis draws on
the recent health effects review published in 2005 by the National Research Council (NRC). We
focus on the potential level of risk borne by the NRC-identified most sensitive subpopulation
(pregnant women and hence their fetuses). Other members of the population should be at a level
of risk below that calculated here, and so protection of the sensitive subpopulation would protect
the general public health. The analysis examines the intersubject distribution of risks to this sensi-
tive subpopulation at various potential drinking water concentrations of perchlorate and also
draws on estimates of the national occurrence of perchlorate in U.S. CWSs to estimate the vari-
ability of risks under deﬁned regulatory scenarios. Results suggest that maximum contaminant lev-
els (MCLs) of up to 24.5 µg/L should pose little or no incremental risk to the large majority of
individuals in the most sensitive subpopulations exposed in the United States at current levels of
perchlorate in water. The protectiveness of an MCL of 24.5 µg/L depends, however, on whether
the study subjects in the health effects data used here may be assumed to have been exposed to
background (non-drinking water) contributions of perchlorate. Key words: Monte Carlo analysis,
perchlorate, risk, sensitive subpopulations, water. Environ Health Perspect 114:975–979 (2006).
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precluded (according to the NRC committee)
by the use of a precursor to adverse effect (iodine
uptake inhibition) in establishing a threshold for
exposure, which was considered by the commit-
tee to represent a health-protective assumption
causing the recommended RfD to be based on a
no observed effect level (NOEL) rather than the
more commonly used no observed adverse
effects level (NOAEL). A NOAEL is by deﬁni-
tion an adverse effect equal to or higher than a
NOEL where the effect used to establish the
NOEL is a precursor to the adverse effect of
interest in establishing a NOAEL.
A possible argument is that a larger un-
certainty factor still is warranted because we do
not know the precise level at which a decrease
in iodine uptake becomes adverse, and so it is
possible that even small decreases may be
adverse in the sense implied by the NOAEL
and the lowest observed adverse effect level
(LOAEL). This would be true especially in the
case of women who already are iodine defi-
cient. The authors of the present article believe
this confuses the concept of an uncertainty fac-
tor as originally developed to argue for RfDs
based on effects judged adverse. The question
is not whether a given decrease in iodine
uptake does or does not lead to adverse effects
in some percentage of the population but
whether such a decrease in and of itself, absent
any sequellae, is to be taken as an adverse
effect. Our position here is that such a decrease
is not adverse in and of itself and so does not
warrant the application of uncertainty factors
developed originally to reason from NOAELs
and LOAELs. The NRC committee appears to
agree, whether explicitly or implicitly.
After the NRC report, the U.S. Environ-
mental Protection Agency (U.S. EPA 2005)
issued a statement accepting the NRC’s RfD
and announcing that it had developed a drink-
ing water equivalent level (DWEL). The
DWEL converts the RfD (represented in units
of mg/kg/day) into an associated concentration
in drinking water (in units of micrograms per
liter), taking into account the relative source
contribution (RSC) from water versus other
exposure routes. The DWEL was established
by the EPA at 24.5 µg/L (U.S. EPA 2005) and
is derived assuming a 70-kg adult consuming
2 L of drinking water per day. This gives an
intake rate (of water) per unit body mass of
0.029 L/kg/day, which is slightly above the
mean value for women of child-bearing age
when both direct and indirect water ingestion
are considered (U.S. EPA 2004, table 6.1.A2).
Hence, use of this value may be considered
conservative (in the sense of being health
protective) for the sensitive subpopulation.
The present article places the NRC assess-
ment into the framework of probabilistic risk
assessment. The question addressed here is
what the distribution of risks is in the sensitive
subpopulation of pregnant women in the
United States resulting from exposure to per-
chlorate in water from community water sup-
plies (CWSs). The term “risk” in this article
has two metrics: a hazard quotient (HQ) and
a percentage reduction in iodide uptake.
These risks then are examined using Monte
Carlo analysis to produce intersubject variabil-
ity distributions under a variety of scenarios of
regulatory interest.
Materials and Methods
Exposure assessment. The occurrence of
perchlorate in drinking waters has recently
been reported in a study sponsored by the
American Water Works Association’s Water
Industry Technical Action Fund (Brandhuber
and Clark 2004). The study relied principally
on data collected under the U.S. EPA unregu-
lated contaminant monitoring rule (UCMR),
supplemented with monitoring data col-
lected by the Massachusetts Department of
Environmental Protection (MDEP), by the
California Department of Health Services
(CalDHS), and in Arizona and Texas
(Brandhuber and Clark 2004). The results
(summarized in Brandhuber and Clark 2004,
table 2.1) provide estimates of the percentage
of CWSs exceeding a variety of proposed
maximum contaminant levels (MCLs) for per-
chlorate. For the U.S. EPA sampling, the per-
centages of CWSs exceeding 2, 4, 6, 10, and
20 µg/L were 4.1, 2.6, 1.6, 0.9, and 0.2%,
respectively. For the CalDHS sampling, the
percentages of CWSs exceeding 2, 4, 6, 10,
and 20 µg/L were 10.5, 5.8, 3.2, 1.5, and
0.3%, respectively. For the MDEP sampling,
the percentages of CWSs exceeding 2, 4, 6,
10, and 20 µg/L were 1.1, 0.8, 0.6, 0.3, and
0.0%, respectively. Data from Arizona and
Texas are not included here because they did
not identify whether a water source was
potable or nonpotable or whether it was part
of a water system. Unfortunately, the data are
insufﬁcient at present to develop a fully proba-
bilistic population-weighted distribution of
concentrations in CWSs, and so the present
analysis assumes no correlation between sys-
tem size (and hence size of population served)
and perchlorate concentration.
The UCMR used analytic methods with a
detection limit of 4 µg/L (micrograms per liter
are essentially the same as parts per billion),
and drew four quarterly samples from each
entry point to the distribution system (EPDS)
for every CWS > 10,000 persons served in the
United States. Data also were collected for a
sample of 771 smaller systems, but this sample
may be too small to provide a sound basis for
statistical inference. These data suggest a
slightly higher concentration in the smallest
water supplies, and so the analysis of
Brandhuber and Clark (2004) may under-
estimate exposures (by up to 20%) in the
small percentage of the population using these
small systems serving fewer than 10,000 peo-
ple. The results reported by Brandhuber and
Clark (2004) and used here reﬂect the UCMR
database compiled as of August 2004, when
the database did not yet contain all the data
from all quarters for all EPDSs. Hence, the
ﬁnal UCMR data set may suggest results that
differ slightly from those discussed here.
The UCMR data reveal detectable
amounts (≥ 4 µg/L) in 1.9% of the samples
taken. Because most CWSs have more than
one EPDS, and samples were taken for each
EPDS, a higher percentage of CWSs (> 1.9%)
were found to have at least one EPDS with
detectable levels of perchlorate. The UCMR
data suggest that perchlorate occurs in
detectable amounts in at least one EPDS asso-
ciated with 5.4% of CWSs. In systems serving
> 10,000 people, perchlorate was detected in
6.1% of groundwater-based CWSs and in
4.9% of the surface-water–fed systems.
Although > 5% of large CWSs in the
UCMR database had some detectable perchlo-
rate in at least one of the EPDS-finished
waters, the levels observed were generally quite
low. More than two-thirds (68%) of the meas-
urable perchlorate concentrations were in the
4–8 ppb range, and 86% were < 12 µg/L.
Only 2.6% of the detected samples had con-
centrations > 24 µg/L (Brandhuber and Clark
2004), which is near the U.S. EPA-designated
DWE of 24.5 µg/L (U.S. EPA 2005). The
highest observed level in the UCMR data was
420 µg/L.
In Massachusetts, samples were analyzed
with a more sensitive detection limit that
yielded quantifiable results ≥ 1 µg/L and
“trace” observations for levels < 1 µg/L. This
method revealed that 2.4% of treated drinking
water samples contained detectable levels of
perchlorate. However, the vast majority of the
Massachusetts detections in treated waters were
at or near the 1-µg/L limit of detection: 66%
of detects in treated drinking water were at
trace levels (≤ 1 µg/L), 83% of detects
were ≤ 2 µg/L, and 90% were ≤ 4 µg/L
(Brandhuber and Clark 2004).
The above data were ﬁt by a lognormal dis-
tribution. The resulting distribution is charac-
terized by a median of 0.03 µg/L and a
geometric standard deviation (GSD) of 13.
The assumption here is that the properties of
the distribution identiﬁed at the higher levels
of exposure (≥ 1 µg/L) continue to apply in
water supplies at concentrations below the
detection limit.
Based on the NRC review, potential for
risk arises only if a person from the sensitive
subpopulation ingests perchlorate at an incre-
mental rate (i.e., above background) that
exceeds the identiﬁed threshold for effect. The
average daily rate of intake (ADRI) for any
individual is based on how much tap water
Crawford-Brown et al.
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rate in their tap water, and their body weight.
These three factors vary across the U.S. popu-
lation of pregnant women. Using available
data, the distributions for these variables can
be included in a Monte Carlo analysis to
develop a combined distribution of ADRI val-
ues across this subpopulation. The distribu-
tion of water ingestion rates used here is based
on total CWS consumption values for adults
established by the U.S. EPA (2004), which
provides values associated with given per-
centiles of the variability distribution.
Data on water ingestion for pregnant
women were too limited to use reliably in this
analysis, but the existing data suggest that
using the data for U.S. adults does not under-
state exposures in pregnant women. As demon-
strated in the U.S EPA Exposure Factors
Handbook (U.S. EPA 1997), the difference in
intake rates of tap water for the general popula-
tion of women of child-bearing age and preg-
nant women is small (mean of 1.16 vs.
1.19 L/day), and so the former is assumed to
approximate the latter intake rates in this
analysis. The distribution of body weight for
25-year-old women (representing women
18–40 years of age, who largely make up the
child-bearing–age population) is taken from
the U.S. EPA Exposure Factors Handbook (U.S.
EPA 1999). The data on water ingestion rate
per unit body weight described above then
were ﬁtted by a lognormal distribution, with a
best ﬁt showing a median of 0.0182 L/kg/day
and a GSD of 1.8. This distribution is consis-
tent with the mean value assumed in regulatory
calculations.
The U.S. EPA typically employs an RSC
of drinking water, expressed as the percentage
of total contaminant dose that is provided by
drinking water, to estimate total risk from all
routes of exposure (i.e., aggregate risk). These
RSCs for drinking water generally are in the
range of 20–80%. The relevance of applying
an RSC here depends on how one interprets
the human subject perchlorate study con-
ducted by Greer et al. (2002) that forms the
basis of the risk coefﬁcients. An RSC is appro-
priate when the study on which risk coeffi-
cients are based includes only exposures
through one route, whereas exposures through
other routes will be present in exposure situa-
tions envisioned in regulatory decisions (and so
must be factored in when regulating exposures
by the ﬁrst route). If one assumes that the indi-
viduals in the study by Greer et al. (2002) were
exposed to the same background levels of per-
chlorate as the rest of the U.S. population
(there is nothing in their diets or in the study
design to preclude this), then no further RSC
adjustment is needed to reﬂect total exposures
via all routes because the risk coefﬁcient from
the study already reﬂects the incremental risk
from ingestion of perchlorate in water above
and beyond the contributions to perchlorate
exposure via the other routes. Similarly,
because the study population presumably was
exposed to the complement of goitergens other
than perchlorate, the study by Greer et al.
(2002) also reﬂects the incremental risk from
ingestion of the goitergen perchlorate above
and beyond the contributions from these other
goitergens. This is the scenario we employ in
our analysis. Unfortunately, adequate data are
not available at present to estimate the RSC for
water exposures reliably.
Risk characterization. A standard metric of
potential health risk for threshold contami-
nants like perchlorate is the HQ. The HQ is
equal to the estimated ADRI (in units of milli-
grams per kilogram per day) divided by the
RfD. An HQ value of 1.0 thus means that a
person is receiving an ADRI equal to the RfD.
Any HQ value ≥ 1.0 indicates that exposure is
at or below the “no risk” threshold (the term
“no risk” here meaning a risk judged to be
nonsigniﬁcant), and thus no signiﬁcant risk of
adverse health effect is anticipated. An HQ
value > 1.0 indicates an ADRI above the RfD
and suggests that there may be some nonzero
risk of adverse health effect (although, because
of the uncertainty factors in the RfD, which
produce a margin of safety, the risk may be
zero even for exposures yielding HQ val-
ues < 1.0). In the present article, we use the
value of RfD suggested by the NRC (2005):
0.0007 mg/kg/day.
Another measure of effect used in this
analysis is the estimated percent decrease in
iodide uptake by the thyroid (the critical effect
used originally to establish the RfD). This is
estimated based on fitting a dose–response
curve to the data from Greer et al. (2002),
relating the ADRI to the percent decrease in
iodide uptake. The resulting curve is shown in
Figure 1. The best model ﬁt is as follows:
Percent decrease in iodide uptake =
70 × {1 – exp[–14 × (ADRI – 0.005)]},
where ADRI is in units of mg/kg/day. Note
that this model suggests a threshold at
0.005 mg/kg/day, which is slightly below the
NOEL for the study at 0.007 mg/kg/day. This
is because there is a measured decrease in
iodine uptake (1.8%) even at the NOEL,
although this decrease is not statistically signiﬁ-
cant. A comparison point for risk here is the
NRC (2005) observation that a 75% decrease
in iodide uptake would be required to initiate a
potential health effect, although again, it must
be noted that the percent decrease required in
the sensitive subpopulation currently is
unknown and is likely to be less than this
value. As before, note that our assumption here
is that the dose–response data from Greer et al.
(2002) reflect the incremental decrease in
iodide uptake per unit incremental increase in
exposure to perchlorate through water alone,
above and beyond the modifying effects of the
background perchlorate exposures through
other routes.
Results
The Monte Carlo assessment was conducted
for hypothetical MCLs of 1, 2, 5, 6, 10, 20,
24.5, and 50 µg/L (values of 6 and 24.5 were
included to reflect potential limits by the
California Environmental Protection Agency
and the U.S. EPA DWEL, respectively). The
analysis was conducted ﬁrst using the national
occurrence distribution to reﬂect nationwide
conditions. In this analysis the actual distribu-
tion of perchlorate concentrations in CWSs is
assumed (median of 0.03 µg/L and GSD of
13), with systems above the MCL mitigated to
exactly the MCL (the nonexceeding systems
remain at their current concentrations). From
this, the distribution of water concentrations in
the United States was established after the
MCL is in place, and a value was selected at
random. An intake rate per unit body mass for
an individual in the sampled population
(women of child-bearing age) then was selected
at random from the distribution described
previously (median of 0.0182 L/kg/day and a
GSD of 1.8). The product of the perchlorate
concentration in water and the intake rate
of water per unit body weight then equals
the ADRI for that sampled individual. The
sampled ADRI was divided by the RfD
(0.007 mg/kg/day) to produce an estimate of
the HQ, then the ADRI was placed into the
model in Figure 1 to produce an estimate of
percentage reduction in iodine uptake. The
Monte Carlo process was repeated for 10,000
individuals to generate intersubject variability
distributions for these two risk metrics. The
value of 10,000 was based on the goal of pro-
viding stability in the tails of the distribution.
Then we focused on intersubject variability
of doses and risk metrics for people possibly
exposed to water mitigated to exactly a poten-
tial MCL to reflect risk distributions only
within those CWSs that currently have ele-
vated perchlorate concentrations and might
therefore be expected to reduce concentrations
Perchlorate risk from water
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Figure 1. Data (circles) on decrease in iodine uptake
in the thyroid versus ADRI for perchlorate in healthy
males and females, averaged over the sexes (the
difference between sexes is not statistically signiﬁ-
cant). Data from Greer et al. (2002). The line is the
best-ﬁtting model as discussed in the text.down to the MCL. The Monte Carlo process
is the same as described previously (including
the focus on the sensitive subpopulation), with
the exception that all individuals are exposed at
the same concentration of perchlorate in water,
equal to the MCL. Both sets of results are
described below.
National occurrence results. The HQ
results using the national occurrence analysis
are summarized in Table 1. For example, at the
95th percentile of the sensitive subpopulation,
the HQ value was 0.02 (i.e., dose was 2% of
the RfD no risk threshold), even at an MCL of
50 µg/L. Note from this same table that the
percent decrease in iodine uptake, using the
model in Figure 1, is zero for all MCL values
and percentiles examined because the ADRI
was below the threshold in the model.
Results for systems at the MCL. In this
second set of calculations, all individuals in
the sensitive subpopulation are assumed
exposed at the concentration of a potential
MCL. In other words, in this analysis, we
examine risks to the highly exposed portion of
the sensitive subpopulation after the potential
MCL has been established and all CWSs are
mitigated down to that MCL.
For the at-the-MCL analysis, some HQ
values do exceed 1.0. As shown in Table 2,
there were no HQ values > 1.0 at MCLs of
≤ 24.5 µg/L for the percentiles of the cumula-
tive distribution functions examined. In systems
with perchlorate concentrations of 50 µg/L,
however, 28.6% of the sensitive subpopulation
had an HQ value exceeding 1.0 (an HQ value
of 1.0 was found at approximately the 71st
percentile of the variability distribution for this
population). At the 90th percentile, the HQ
value at 50 µg/L exposure was 1.54, and at the
95th percentile the HQ value was 1.89. There
was, however, no reduction in iodide uptake
estimated from the model at any MCL because
all intake rates were below the threshold for the
model in Figure 1.
Sensitivity analyses. The above-described
analyses and results are based on several
assumptions that can be altered. We conducted
several alternate Monte Carlo simulations to
reﬂect a mix of potential differences in selection
of underlying data or in how those data are
interpreted. The goal here was to determine an
upper-bound estimate of the risks, and so more
conservative assumptions were used than was
the case in Tables 1 and 2. Speciﬁcally, in this
new analysis, the amount of water consumed
was increased to include total water intake (not
just intake from CWSs), as obtained from the
U.S. EPA Exposure Factors Handbook (U.S.
EPA 1999). Using the national occurrence data
for the concentration of perchlorate in the
drinking water (i.e., assuming the non-CWS
concentration was the same as that in the CWS
for an individual), there is no appreciable differ-
ence between the base case results from Table 1
and the “upper-end” values calculated here.
Results in Table 1 may therefore be assumed
to represent upper-end risks when all water
consumption, and not only drinking water, is
considered in the exposure assessment.
However, for the at-the-MCL analysis
results (as shown in Table 3, and equivalent to
Table 2), for those women consuming water
with perchlorate at the potential MCLs, there
are some elevated HQ values compared with
those in the base analysis depicted in Table 2.
In particular, there are now HQ values > 1.0
at the 95th percentile even at 20 µg/L.
Discussion and Conclusions
Perchlorate in drinking water is more wide-
spread than originally anticipated, with per-
haps 2% of sources showing detectable levels
≥ 4 µg/L. Combining the newly emerging risk
and occurrence information, we have modeled
the percentage of the sensitive subpopulation
(pregnant women) that may face (or whose
infants may face) a risk of adverse health effects
due to perchlorate in U.S. drinking waters.
The results indicate that for any population
using a CWS with a perchlorate concentration
of 50 µg/L (i.e., slightly more than twice the
proposed U.S. EPA DWEL of 24.5 µg/L),
there would be an appreciable percentage of
pregnant women who face a risk of adverse
effects in themselves or their fetuses because
they would have an HQ value > 1.0. When
perchlorate concentrations are 50 µg/L,
between 28.6% (if only ingestion of drinking
water is assumed) and 58.1% (if all water
ingestion is assumed, with the non-CWS being
Crawford-Brown et al.
978 VOLUME 114 | NUMBER 7 | July 2006 • Environmental Health Perspectives
Table 1. HQ values for pregnant women (the sensitive subpopulation): base case analysis, using national
occurrence data (i.e., existing distribution of perchlorate in water, with only supplies currently above the
proposed MCL mitigated down to the proposed MCL).
MCL (µg/L) Mediana 90th percentileb 95th percentileb Percent HQ < 1c Percent decreased
1 0.01 0.02 0.02 > 99 0
2 0.01 0.02 0.02 > 99 0
5 0.01 0.02 0.02 > 99 0
6 0.01 0.02 0.02 > 99 0
10 0.01 0.02 0.02 > 99 0
20 0.01 0.02 0.02 > 99 0
24.5 0.01 0.02 0.02 > 99 0
50 0.01 0.02 0.02 > 99 0
aThe median for the variability distribution. bThe 90th and 95th percentiles of the variability distribution. cThe percentage
of the population with an HQ value < 1. dThe percent decrease in iodide uptake for individuals at the 95th percentile. The
percent decrease is predicted using the equation in the text; a value of 0% indicates the modeled threshold of
0.005 mg/kg/day has not been exceeded.
Table 2. HQ values for pregnant women (the sensitive subpopulation): base case analysis, for persons
using CWSs at the MCL concentration (i.e., considering only supplies currently above a potential MCL,
which are mitigated down to the potential MCL).
MCL (µg/L) Mediana 90th percentileb 95th percentileb Percent HQ < 1c Percent decreased
1 0.01 0.03 0.04 > 99 0
2 0.03 0.06 0.08 > 99 0
5 0.07 0.15 0.19 > 99 0
6 0.08 0.19 0.22 > 99 0
10 0.14 0.30 0.38 > 99 0
20 0.29 0.62 0.76 > 99 0
24.5 0.33 0.70 0.90 > 99 0
50 0.73 1.54 1.89 71.4 0
aThe median for the variability distribution. bThe 90th and 95th percentiles of the variability distribution. cThe percentage
of the population with an HQ value < 1. dThe percent decrease in iodide uptake for individuals at the 95th percentile. The
percent decrease is predicted using the equation in the text; a value of 0% indicates the threshold of 0.005 mg/kg/day has
not been exceeded.
Table 3. HQ values for pregnant women (the sensitive subpopulation): sensitivity analysis, high-end expo-
sure scenarios for persons consuming all water, and not only drinking water, at the MCL.
MCL (µg/L) Mediana 90th percentileb 95th percentileb Percent HQ < 1c Percent decreased
1 0.04 0.07 0.08 > 99 0
2 0.06 0.11 0.13 > 99 0
5 0.13 0.25 0.31 > 99 0
6 0.15 0.28 0.36 > 99 0
10 0.24 0.48 0.60 > 99 0
20 0.45 0.95 1.16 91.2 0
24.5 0.50 1.10 1.35 88.3 0
50 1.10 2.37 2.90 41.9 0
aThe median for the variability distribution. bThe 90th and 95th percentiles of the variability distribution. cThe percentage
of the population with an HQ value < 1. dThe percent decrease in iodide uptake for individuals at the 95th percentile. The
percent decrease is predicted using the equation in the text; a value of 0% indicates the threshold of 0.005 mg/kg-day has
not been exceeded.Perchlorate risk from water
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similarly contaminated by perchlorate) of the
sensitive subpopulation might face a dose
exceeding the RfD. Values of the HQ > 1.0 at
the 95th percentile of the intersubject variabil-
ity distribution are predicted at 20 µg/L per-
chlorate if ingestion of all water, and not only
drinking water, is included in the exposure
assessment. The results suggest that few
women in the sensitive subpopulation would
face a signiﬁcant perchlorate risk from drinking
water at MCLs ≤ 24.5 µg/L if only drinking
water is considered, but that the equivalent
MCL would need to be slightly below 20 µg/L
if all water ingestion were considered.
We caution the reader on the interpreta-
tion of these results. The present analysis falls
within a framework of probabilistic risk
assessment that differs in significant ways
from traditional approaches to determining
regulatory limits on exposure. In those tradi-
tional approaches, risks are estimated to maxi-
mally exposed individuals within sensitive
subpopulations, and the concentration deter-
mined that produces an acceptable level of
risk in those individuals. This level is in-
dependent of any consideration of the frac-
tion of people in that subpopulation. The
question being addressed traditionally is to
what extent a proposed MCL will reduce the
risk to an individual in this maximally
exposed, sensitive subpopulation.
Probabilistic risk assessment as conducted
here, however, examines the intersubject
variability distribution of risks in this sub-
population and asks what fraction of people
in an exposed population have a risk (HQ or
percentage decrease in iodide uptake) judged
to be unacceptable. Such probabilistic
distributions form the basis of cost–risk–
beneﬁt calculations, allowing society to deter-
mine how a given mode of risk reduction (e.g.,
controls on perchlorate exposures) compares
against other modes of risk reduction. The goal
then is to determine the total burden of disease
in a population and to use this estimate of bur-
den to determine whether the examined mode
of risk reduction (here, control on perchlorate
exposures) represents an effective way to allo-
cate limited societal resources in improving the
overall health of the public. We have not
attempted here to draw any conclusions in that
regard, but rather to present the probabilistic
information on which such cost–risk–beneﬁt
assessments might be based.
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There is broad scientiﬁc agreement that the mode
of action for perchlorate is as follows:
• Perchlorate binds to, and blocks, receptors for
the movement of iodine from the bloodstream
into the thyroid. This will reduce the movement
of iodine into the thyroid.
• The thyroid responds to this reduction either by
producing less triiodothyronine (T3) and thyrox-
ine (T4) or by drawing on the pool of iodine
stored in the thyroid.
• Perchlorate can therefore reduce the production
of T3 and T4 initially, although there are feedback
mechanisms that can bring these levels in the cir-
culating blood back to normal ranges over time. 
• The effect on T4 is not signiﬁcant because that
molecule is an intermediary, and so the focus
should be on changes in T3.
• For some fraction of the population that has
very little iodine stored in the thyroid, there
may be reduced ability to compensate for the
reduction of iodine crossing from the blood-
stream to the thyroid. This may reduce T3 levels
in the circulating blood, leading eventually to
increased production of thyroid-stimulating
hormone (TSH) to try to correct the imbalance.
• If the imbalance cannot be corrected, there could
be changes in metabolic function at any age of
exposure, or abnormal fetal and child growth
and development.
The NRC committee (NRC 2005) disagreed as to
where the U.S. EPA should draw the line between
adverse and nonadverse effects. The agency consid-
ered changes in T3 and TSH levels to be adverse in
and of themselves, or at least indications of, or bio-
markers of, adverse effects. The NRC committee
did not consider changes in T3 and/or TSH
adverse in and of themselves. Instead, the NRC
committee claimed that changes in these levels
must ﬁrst produce thyroid hypertrophy or hyper-
plasia, followed by hypothyroidism, which then
will produce the ﬁnal metabolic and growth/devel-
opmental effects mentioned above. The NRC
committee considered the ﬁrst effect that is adverse
to be hypothyroidism rather than either the preced-
ing thyroid hypertrophy/hyperplasia or the changes
in T3 and/or TSH.
Appendix. Mode of action for perchlorate. 